Patents by Inventor Wallace G. Strycker

Wallace G. Strycker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5212066
    Abstract: Disclosed is a novel diagnostic reagent system for the detection of hydroperoxides or substances which react with peroxidatively active substances resulting in the liberation of hydroperoxides which reagent system comprises a chromogenic oxidation indicator and a peroxidase or a peroxidatively active substance, together with an inhibitor of color generation selected from the group of 1,4-disubstituted semicarbazides, thiosemicarbazides and 1,5-disubstituted carbazides as inhibitors of color generation. By inhibiting the generation of color formed by oxidation of the chromogenic indicator, the indicator's usefulness in discriminating between varying concentrations of analyte is enhanced.
    Type: Grant
    Filed: November 14, 1991
    Date of Patent: May 18, 1993
    Assignee: Miles Inc.
    Inventors: James P. Albarella, Todd K. Cast, David W. Michaels, Wallace G. Strycker
  • Patent number: 4304913
    Abstract: Disclosed are trans-2-substituted-amido-hexahydrobenzo[a]quinolizines represented by the formula: ##STR1## In the above formula, R.sup.1 and R.sup.2 are independently --H or --OCH.sub.3 or when taken together are ##STR2## R.sup.3 is --H or --CH.sub.3 and R.sup.4 is ##STR3## These compounds, and their pharmacologically acceptable, non-toxic, acid addition salts are useful as anti-hypertensive agents.
    Type: Grant
    Filed: October 2, 1980
    Date of Patent: December 8, 1981
    Assignee: Miles Laboratories, Inc.
    Inventors: Herbert J. Havera, Wallace G. Strycker
  • Patent number: 4230710
    Abstract: Disclosed are novel 2-substituted anilino-hexahydrobenzo[a]quinolizines of the formula: ##STR1## wherein R and R' are independently H or --OCH.sub.3 and R" is ##STR2## These compounds, and their pharmacologically acceptable, non-toxic acid addition salts are useful as anti-hypertensive agents. Certain of the compounds disclosed herein elicit this effect without producing concomitant cardiac stimulation.
    Type: Grant
    Filed: October 23, 1978
    Date of Patent: October 28, 1980
    Assignee: Miles Laboratories, Inc.
    Inventors: Herbert J. Havera, Wallace G. Strycker
  • Patent number: 4110536
    Abstract: Derivatives of 5-(indol-3-yl)hydantoin characterized by the generic structural formula, ##STR1## and their pharmacologically compatible salts are useful in the treatment of cardiac arrythmias in individuals for whom such therapy is indicated. In the preceding structural formula, A is a hydrogen atom, a halogeno, alkyl, hydroxyl, or an alkoxyl radical; n is 0 or 1; R is a hydrogen atom or a phenyl group; X is a methylene, ethylene, trimethylene, or 2-hydroxytrimethylene radical; and Z is a monoalkylamino radical containing 1-4 carbon atoms, a dialkylamino radical containing 2-8 carbon atoms, a morpholino, piperid-1-yl, 4-phenyl-piperid-1-yl, or a 4-hydroxy-4-phenyl-piperid-1-yl radical.
    Type: Grant
    Filed: April 18, 1977
    Date of Patent: August 29, 1978
    Assignee: Miles Laboratories, Inc.
    Inventors: Herbert J. Havera, Wallace G. Strycker